Actively Recruiting
Mi-RNA and COVID-19
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-03-18
49
Participants Needed
1
Research Sites
404 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), induces a spectrum of clinical conditions ranging from asymptomatic infection to life threatening severe disease, characterized by respiratory failure, shock and multi-organ dysfunction requiring admission in the intensive care unit (ICU). The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.
CONDITIONS
Official Title
Mi-RNA and COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosis of SARS-CoV-2 infection confirmed by molecular testing on nasopharyngeal swabs
You will not qualify if you...
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, Italy, 00167
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here